Literature DB >> 17299127

High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention.

Claus Thamer1, Juergen Machann, Norbert Stefan, Michael Haap, Silke Schäfer, Sonja Brenner, Konstantin Kantartzis, Claus Claussen, Fritz Schick, Hans Haring, Andreas Fritsche.   

Abstract

OBJECTIVE: High visceral adipose tissue (VAT) and high liver fat (LF) are associated with the metabolic syndrome and diabetes. We studied changes in these two fat depots during weight loss and analyzed whether VAT and LF at baseline predict the response to lifestyle intervention. RESEARCH METHODS AND PROCEDURES: One hundred twelve subjects (48 men and 64 women; age, 46 +/- 11 years; BMI, 29.2 +/- 4.4 kg/m(2)) were studied after a follow up-time of 264 +/- 60 (SD) days. Insulin sensitivity was estimated from the oral glucose tolerance test. Body fat depots were quantified using magnetic resonance imaging and spectroscopy.
RESULTS: Cross-sectionally high VAT (r = -0.22, p = 0.02) and high LF (r = -0.36, p < 0.0001) were independently associated with low insulin sensitivity. With intervention, BMI (-3.0%), VAT (-12.0%), and LF (-33.0%) were reduced (all p < 0.001). Insulin sensitivity was improved (+17%, p < 0.01). The changes in BMI (r = -0.41), VAT (r = -0.28), and LF (r = -0.39) were associated with the increase in insulin sensitivity (all p < 0.01). High VAT (r = -0.28, p = 0.01) and high LF (r = -0.38, p < 0.01) at baseline were associated with a lesser increase in insulin sensitivity. DISCUSSION: Baseline values and changes in BMI, VAT, and LF are related to changes in insulin sensitivity during lifestyle intervention. Subjects with high VAT and LF have a lower chance of profiting from lifestyle intervention and may require intensified lifestyle prevention strategies or even pharmacological approaches to improve insulin sensitivity.

Entities:  

Mesh:

Year:  2007        PMID: 17299127     DOI: 10.1038/oby.2007.568

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc Hickson; Aurelian Bidulescu; J Jeffery Carr; Herman A Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

3.  Impact of different fat depots on insulin sensitivity: predominant role of liver fat.

Authors:  Kerstin Kirchhoff; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Diabetes Sci Technol       Date:  2007-09

4.  Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan; Erik P Kirk; Bettina Mittendorfer; Bruce W Patterson; Samuel Klein
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

5.  [Liver volume, intrahepatic fat and body weight in the course of a lifestyle interventional study: Analysis with quantitative MR-based methods].

Authors:  M N Bongers; N Stefan; A Fritsche; H-U Häring; K Nikolaou; F Schick; J Machann
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

Review 6.  The impact of insulin resistance on the kidney and vasculature.

Authors:  Ferruh Artunc; Erwin Schleicher; Cora Weigert; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

7.  Response heterogeneity to lifestyle intervention among Latino adolescents.

Authors:  Armando Peña; Daniel McNeish; Stephanie L Ayers; Micah L Olson; Kiley B Vander Wyst; Allison N Williams; Gabriel Q Shaibi
Journal:  Pediatr Diabetes       Date:  2020-10-08       Impact factor: 4.866

8.  Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses.

Authors:  Yoshiko Fukuyama; Daisuke Tokuhara; Shinichi Sekine; Kosuke Kataoka; Jonathan D Markham; Allyson R Irwin; Grace H Moon; Yuka Tokuhara; Keiko Fujihashi; Julia Davydova; Masato Yamamoto; Rebekah S Gilbert; Kohtaro Fujihashi
Journal:  Biochem Biophys Res Commun       Date:  2011-12-19       Impact factor: 3.575

9.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

10.  The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies.

Authors:  Peter Weyrich; Harald Staiger; Alena Stančáková; Fausto Machicao; Jürgen Machann; Fritz Schick; Norbert Stefan; Johanna Kuusisto; Markku Laakso; Silke Schäfer; Andreas Fritsche; Hans-Ulrich Häring
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.